Australia 200

CSL, Resmed, Ramsay and Sonic Healthcare, are they in the buy zone? | Switzer Investing

Listen to the audio version here:

00:00 Intro
01:19 Peter and Paul discuss if Healthcare will shine?
10:21 Raymond Chan
22:06 Marcus Bogdan
33:21 Outro

Subscribe to Switzer:
Switzer Report –
Switzer Daily –
The Peter Switzer Show –

Follow Switzer:
YouTube ––i1gA?sub_confirmation=1
Facebook –
Twitter –
LinkedIn –—publishing

#asx #sharemarket #stocks


Related Articles


  1. I can never understand why CSL is held in high regard and as a growth stock. Its closing price today is $293.33, on a P/E of 41. It first hit that price on January 10th 2020. Earning in that year $6.72, last year $7.35, so about 10% growth over two year, or 5%pc pa. The dividend now is 1.2% pa partially franked. Why would you hold it?

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button